Yoshiaki Ito, Tokio Matsuzaki, Fumiaki Ayabe, Sho Mokuda, Ryota Kurimoto, Takahide Matsushima, Yusuke Tabata, Maiko Inotsume, Hiroki Tsutsumi, Lin Liu, Masahiro Shinohara, Yoko Tanaka, Ryo Nakamichi, Keiichiro Nishida, Martin K Lotz, Hiroshi Asahara. Both microRNA-455-5p and -3p repress hypoxia-inducible factor-2α expression and coordinately regulate cartilage homeostasis. Nat Commun. 2021.07; 12 (1): 4148. ( PubMed, DOI )

Takayuki Miyazaki, Ryota Kurimoto, Tomoki Chiba, Takahide Matsushima, Ryo Nakamichi, Hiroki Tsutsumi, Kaho Takada, Lisa Yagasaki, Tomomi Kato, Kana Shishido, Yukiho Kobayashi, Tsutomu Matsumoto, Keiji Moriyama, Hiroshi Asahara. Mkx regulates the orthodontic tooth movement via osteoclast induction. J Bone Miner Metab. 2021.05; ( PubMed, DOI )

Yutaro Uchida, Takahide Matsushima, Ryota Kurimoto, Tomoki Chiba, Yuki Inutani, Hiroshi Asahara. Identification of chemical compounds regulating PD-L1 by introducing HiBiT-tagged cells. FEBS Lett. 2021.03; 595 (5): 563-576. ( PubMed, DOI )

Chiba T, Kurimoto R, Matsushima T, Ito Y, Nakamichi R, Lotz M, Asahara H. MicroRNA Expression Profiling, Target Identification, and Validation in Chondrocytes. Methods in molecular biology (Clifton, N.J.). 2021; 2245 151-166. ( PubMed, DOI )

Kurimoto R, Chiba T, Ito Y, Matsushima T, Yano Y, Miyata K, Yashiro Y, Suzuki T, Tomita K, Asahara H. The tRNA pseudouridine synthase TruB1 regulates the maturation of let-7 miRNA. The EMBO journal. 2020.09; e104708. ( PubMed, DOI )

Nakamichi Ryo, Kurimoto Ryota, Tabata Yusuke, Asahara Hirosi. Transcriptional, epigenetic and microRNA regulation of growth plate BONE. 2020.08; 137 115434. ( PubMed, DOI )

Kurimoto R, Sakurai K, Motoori K, Suda A. A case of COVID-19 with the atypical CT finding. Clinical case reports. 2020.07; ( PubMed, DOI )

Kataoka Kensuke, Kurimoto Ryota, Tsutsumi Hiroki, Chiba Tomoki, Kato Tomomi, Shishido Kana, Kato Mariko, Ito Yoshiaki, Cho Yuichiro, Hoshi Osamu, Mimata Ayako, Sakamaki Yuriko, Nakamichi Ryo, Lotz Martin K., Naruse Keiji, Asahara Hiroshi. In vitroNeo-Genesis of Tendon/Ligament-Like Tissue by Combination of Mohawk and a Three-Dimensional Cyclic Mechanical Stretch Culture System FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. 2020.06; 8 307. ( PubMed, DOI )

Yamamoto H, Uchida Y, Chiba T, Kurimoto R, Matsushima T, Inotsume M, Ishikawa C, Li H, Shiga T, Muratani M, Uchida T, Asahara H. Transcriptome analysis of sevoflurane exposure effects at the different brain regions. PloS one. 2020; 15 (12): e0236771. ( PubMed, DOI )

Uchida Yutaro, Chiba Tomoki, Kurimoto Ryota, Asahara Hiroshi. Post-transcriptional regulation of inflammation by RNA-binding proteins via cis-elements of mRNAs JOURNAL OF BIOCHEMISTRY. 2019.11; 166 (5): 375-382. ( PubMed, DOI )

Uchida Yutaro, Chiba Tomoki, Kurimoto Ryota, Asahara Hiroshi. RNA結合蛋白質によるmRNAのシスエレメントを介した炎症の転写後調節(Post-transcriptional regulation of inflammation by RNA-binding proteins via cis-elements of mRNAs) The Journal of Biochemistry. 2019.11; 166 (5): 375-382. ( ichushi )

Kurimoto Ryota, Tsutsumi Hiroki, Uchida Yutaro, Asahara Hiroshi. New regulatory mechanism of tumor suppressor microRNA let-7s (comprehensive approach for tumor suppressors in vitro) ANNALS OF ONCOLOGY. 2019.10; 30 ( DOI )

Mitsumura T, Ito Y, Chiba T, Matsushima T, Kurimoto R, Tanaka Y, Kato T, Uchida K, Ito T, Yamamoto K, Eishi Y, Kitagawa M, Miyazaki Y, Inase N, Asahara H. Ablation of miR-146b in mice causes hematopoietic malignancy. Blood advances. 2018.12; 2 (23): 3483-3491. ( PubMed, DOI )

Kurimoto R, Ebata T, Iwasawa S, Ishiwata T, Tada Y, Tatsumi K, Takiguchi Y. Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma. Oncology letters. 2017.07; 14 (1): 944-950. ( PubMed, DOI )

Kurimoto R, Iwasawa S, Ebata T, Ishiwata T, Tada Y, Tatsumi K, Takiguchi Y. Pirfenidone in reversion of the epithelial-to-mesenchymal transition in human lung adenocarcinoma. Oncology Letters. 2017.05; 14 (1): 944-950.

Emiko Sakaida, Takahiro Ebata, Shunichiro Iwasawa, Ryota Kurimoto, Sachiko Yonemori, Satoshi Ota, Yukio Nakatani, Ikuo Sekine, Yuichi Takiguchi. Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell Carcinoma. Internal Medicine. 2017.03; 56 (5): 567-570.

Sakaida Emiko, Ebata Takahiro, Iwasawa Shunichiro, Kurimoto Ryota, Yonemori Sachiko, Ota Satoshi, Nakatani Yukio, Sekine Ikuo, Takiguchi Yuichi. メルケル細胞癌に対するサルベージ療法としてのアムルビシンの潜在的活性(Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell Carcinoma) Internal Medicine. 2017.03; 56 (5): 567-570. ( ichushi )

Sakaida E, Ebata T, Iwasawa S, Kurimoto R, Yonemori S, Ota S, Nakatani Y, Sekine I, Takiguchi Y. Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell Carcinoma. Internal medicine (Tokyo, Japan). 2017; 56 (5): 567-570. ( PubMed, DOI )

Kurimoto Ryota, Ikeda Kei, Nakagomi Daiki, Nakajima Hiroshi. [18F]FDG-PET/CTで描出された好酸球性筋膜炎(Eosinophilic Fasciitis Illustrated by [18F] FDG-PET/CT) Internal Medicine. 2016.08; 55 (16): 2321-2322. ( ichushi )

Kurimoto Ryota, Shono Katsuhiro, Onoda Masahiro, Yamamoto Kyohei, Yokota Akira. メトトレキサート治療に関連した関節リウマチ患者のMYC/BCL2ダブルヒットリンパ腫(MYC/BCL2 Double-hit Lymphoma in a Patient with Rheumatoid Arthritis Associated with Methotrexate Treatment) Internal Medicine. 2016.08; 55 (16): 2271-2275. ( ichushi )

Ryota Kurimoto, Shunichiro Iwasawa, Takahiro Ebata, Tsukasa Ishiwata, Ikuo Sekine, Yuji Tada, Koichiro Tatsumi, Shuhei Koide, Atsushi Iwama, Yuichi Takiguchi. Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation. Int. J. Oncol.. 2016.05; 48 (5): 1825-1836. ( PubMed, DOI )

Emiko Sakaida, Shunichiro Iwasawa, Ryota Kurimoto, Takahiro Ebata, Chiaki Imai, Tomoko Oku, Ikuo Sekine, Yuji Tada, Koichiro Tatsumi, Yuichi Takiguchi. Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study. Jpn. J. Clin. Oncol.. 2016.04; 46 (4): 370-377. ( PubMed, DOI )

Sakaida Emiko, Iwasawa Shunichiro, Kurimoto Ryota, Ebata Takahiro, Imai Chiaki, Oku Tomoko, Sekine Ikuo, Tada Yuji, Tatsumi Koichiro, Takiguchi Yuichi. Cisplatin投与におけるshort hydration法の安全性の従来法との比較　後向き研究(Safety of a short hydration method for cisplatin administration in comparison with a conventional method: a retrospective study) Japanese Journal of Clinical Oncology. 2016.04; 46 (4): 370-377. ( ichushi )

Tsukasa Ishiwata, Shunichiro Iwasawa, Ryota Kurimoto, Takahiro Ebata, Yuichi Takiguchi. Prophylactic dexamethasone for radiation-induced bone-pain flare. Lancet Oncol.. 2016.02; 17 (2): e39-e40. ( PubMed, DOI )

Ryota Kurimoto, Katsuhiro Shono, Masahiro Onoda, Kyohei Yamamoto, Akira Yokota. MYC/BCL2 Double-hit Lymphoma in a Patient with Rheumatoid Arthritis Associated with Methotrexate Treatment. Intern. Med.. 2016; 55 (16): 2271-2275. ( PubMed, DOI )

Ryota Kurimoto, Kei Ikeda, Daiki Nakagomi, Hiroshi Nakajima. Eosinophilic Fasciitis Illustrated by [(18)F] FDG-PET/CT. Intern. Med.. 2016; 55 (16): 2321-2322. ( PubMed, DOI )

Yamada K, Saito H, Kondo T, Murakami S, Masuda N, Yamamoto M, Igawa S, Katono K, Takiguchi Y, Iwasawa S, Kurimoto R, Okamoto H, Shimokawa T, Hosomi Y, Takagi Y, Kishi K, Ohba M, Oshita F, Watanabe K. Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910. Anticancer research. 2015.12; 35 (12): 6705-11. ( PubMed )

Kurimoto Ryota, Sekine Ikuo, Iwasawa Shunichiro, Sakaida Emiko, Tada Yuji, Tatsumi Koichiro, Takahashi Yoko, Nakatani Yukio, Imai Chiaki, Takiguchi Yuichi. ペメトレキセド投与に関連した肺胞出血(Alveolar Hemorrhage Associated with Pemetrexed Administration) Internal Medicine. 2015.04; 54 (7): 833-836. ( ichushi )

Kurimoto R, Sekine I, Iwasawa S, Sakaida E, Tada Y, Tatsumi K, Takahashi Y, Nakatani Y, Imai C, Takiguchi Y. Alveolar hemorrhage associated with pemetrexed administration. Internal medicine (Tokyo, Japan). 2015; 54 (7): 833-6. ( PubMed, DOI )

Ishii T, Iwasawa S, Kurimoto R, Maeda A, Takiguchi Y, Kaneda M. Crizotinib-Induced Abnormal Signal Processing in the Retina. PloS one. 2015; 10 (8): e0135521. ( PubMed, DOI )

Takiguchi Y, Sekine I, Iwasawa S, Kurimoto R, Tatsumi K. Chronic obstructive pulmonary disease as a risk factor for lung cancer. World journal of clinical oncology. 2014.10; 5 (4): 660-6. ( PubMed, DOI )

Takiguchi Y, Sekine I, Iwasawa S, Kurimoto R, Sakaida E, Tamura K. Current status of medical oncology in Japan--reality gleaned from a questionnaire sent to designated cancer care hospitals. Japanese journal of clinical oncology. 2014.07; 44 (7): 632-40. ( PubMed, DOI )

Takiguchi Yuichi, Sekine Ikuo, Iwasawa Shunichiro, Kurimoto Ryota, Sakaida Emiko, Tamura Kenji. 日本における内科的腫瘍学の現状　がん診療連携拠点病院に送付した質問紙調査から明らかになった現実(Current Status of Medical Oncology in Japan: Reality Gleaned from a Questionnaire Sent to Designated Cancer Care Hospitals) Japanese Journal of Clinical Oncology. 2014.07; 44 (7): 632-640. ( ichushi )

Takiguchi Y, Sekine I, Iwasawa S, Kurimoto R, Uehara T. Stereotactic radiosurgery for patients with brain metastases. The Lancet. Oncology. 2014.06; 15 (7): e247-8. ( PubMed, DOI )

Sakaida E, Sekine I, Iwasawa S, Kurimoto R, Uehara T, Ooka Y, Akanuma N, Tada Y, Imai C, Oku T, Takiguchi Y. Incidence, risk factors and treatment outcomes of extravasation of cytotoxic agents in an outpatient chemotherapy clinic. Japanese journal of clinical oncology. 2014.02; 44 (2): 168-71. ( PubMed, DOI )

Sakaida Emiko, Sekine Ikuo, Iwasawa Shunichiro, Kurimoto Ryota, Uehara Takashi, Ooka Yoshihiko, Akanuma Naoki, Tada Yuji, Imai Chiaki, Oku Tomoko, Takiguchi Yuichi. 外来化学療法クリニックにおける細胞毒性薬の血管外漏出の発生率、危険因子、治療転帰(Incidence, Risk Factors and Treatment Outcomes of Extravasation of Cytotoxic Agents in an Outpatient Chemotherapy Clinic) Japanese Journal of Clinical Oncology. 2014.02; 44 (2): 168-171. ( ichushi )

Shimomura I, Tada Y, Miura G, Suzuki T, Matsumura T, Tsushima K, Terada J, Kurimoto R, Sakaida E, Sekine I, Takiguchi Y, Yamamoto S, Tatsumi K. Choroidal metastasis of non-small cell lung cancer that responded to gefitinib. Case reports in ophthalmological medicine. 2013; 2013 213124. ( PubMed, DOI )

Ryota Kurimoto, Waka Miyamoto, Maiko Inotsume, Tomoki Chiba, TakahideMatsushima, YutaroUchida, Yuta Fujii, Hiroshi Asahara.. Regulation of lung cancer metastasis by the RNA-modifying enzyme. 2022.07.21

Lisa Yagasaki, Tomoki Chiba, Ryota Kurimoto, Takanori Iwata, Hiroshi Asahara. Understanding the role of Mkx in periodontal disease through utilisation of Mkx knockout rats. 第7回日本骨免疫学会 2022.06.30

Lin Liu, Tomoki Chiba, Ryota Kurimoto, Hiroki Tsutsumi, Yuta Fujii, Hiroshi Asahara. Single-cell transcriptome profiles in mouse limb buds . 第7回日本筋学会学術集会 2021.12.11

Yutaro Uchida, Takahide Matsushima, Ryota Kurimoto, Tomoki Chiba, Yuki lnutani, Hiroshi Asahara.. HiBiT tagging system for high throughput chemical screening for chemotherapy. AACR 2021 2021.04.11

Ryota Kurimoto, Hiroki Tsutsumi, Saki lkeuchi, Hiroshi Asahara. Tumor suppression potential of tRNA modification enzyme TruBs via let-7. AACR 2021 2021.04.10

Ryota Kurimoto, Hiroshi Asahara. The tRNA pseudouridine synthase TruB1 regulates the maturation of let-7 miRNA.. 第2回RNAJオンラインミーティング 2020.08.27 Tokyo

Ryota Kurimoto, Hiroki Tsutsumi, Maiko Inotsume, Hiroshi Asahara. New regulatory mechanism of tumor suppressor microRNA let-7s. 16thn Bone Biology Forum 2019.08.16 Makuhari, Chiba, Japan

Ryota Kurimoto, Hiroki Tsutsumi, Hiroshi Asahara. New regulatory mechanism of tumor suppressor microRNA let-7s (comprehensive approach for tumor suppressors in vitro) . 16th Meeting of Bone Biology Forum 2019.08.16

Ryota Kurimoto, Hiroki Tsutsumi, Yutaro Uchida, Hiroshi Asahara. 腫瘍抑制microRNA let-7 familyの新たな制御機構の解明. 第17回日本臨床腫瘍学会 2019.07.19

Hiroshi Asahara, Sho Mokuda, Yoshiaki Ito, Masafumi Inui, Ryo Nakamichi, Tomoki Chiba, Ryota Kurimoto, Takahide Matsushima. miRNAs in arthritis pathogenesis and therapy. The 24th Annual Meeting of the RNA Society 2019.06.14

Ryota Kurimoto, Shunichiro Iwasawa, Takahiro Ebata, Tsukasa Ishiwata, Ikuo Sekine, Yuji Tada, Koichiro Tatsumi, Shuhei Koide, Atsushi Iwama, Yuichi Takiguchi. . Alteration of drug sensitivity according to the induction and reversion of epithelial-to-mesenchymal transition (EMT) in human lung adenocarcinoma cell lines harboring an EGFR mutation.. American Association for Cancer Research Annual Meeting 2016 2016